NEW YORK – A new test from Abbott, developed in collaboration with the Mayo Clinic, uses a self-administered tampon to collect samples to test for endometrial cancer.
Already a GenomeWeb member? LoginLogin
Get the full story with GenomeWeb Premium
Only $95 for the first 90 days
Benefits:
Full site access
Interest-based email alerts
Access to archives
Premium Access - Trial Offer
$95.00 for 3 month
Benefits:
Full site access
Interest-based email alerts
Access to archives
Already a GenomeWeb member? LoginLogin
